Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2015

01-08-2015 | Research Article

Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests

Authors: Tugba Arikoglu, Gulen Aslan, Sehra Birgul Batmaz, Gulcin Eskandari, Ilter Helvaci, Semanur Kuyucu

Published in: International Journal of Clinical Pharmacy | Issue 4/2015

Login to get access

Abstract

Background Parent or self-reported drug allergy claims frequently overestimate the real incidence of hypersensitivity reactions. A detailed and algorithmic diagnostic evaluation of drug reactions may allow a proper diagnosis. Objective The aim of this study was to determine the confirmation rates and risk factors for confirmed allergic drug reactions in children. Setting Mersin University Hospital in Turkey. Method The study consisted of children between ages of 8 months and 18 years with the history of suspected drug allergy as reported by the clinician or the patients. Parents were interviewed by a clinician to complete questionnaires that included questions about demographic data and characteristics of index drug reaction. Immediate reactions (IRs) were assessed with immediate-reading skin prick (SPT) and intradermal tests (IDT). Nonimmediate reactions (NIRs) were assessed with SPT, both early and delayed reading of IDT and patch tests. In case of negative skin tests, drug provocation tests were performed. The possible risk factors for confirmed drug allergy in univariate analysis (p < 0.1) were entered into the multivariate logistic regression analysis to determine independent predictors. Main outcome measure (1) Confirmation rates of drug allergy (2) Risk factors related to confirmed drug allergy in children. Results We evaluated a total of 180 suspected drug allergy reactions in 97 children, mainly to antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants. Among all suspected allergic drug reactions, 97 (53.9 %) were immediate type and 83 (46.1 %) were non-immediate type. The average time interval between the reaction and allergologic work-up was 5 months. Drug allergy confirmation rates were 30.1 % for beta-lactams, 27.2 % for non-betalactams, 21.1 % for NSAIDs and 30 % for anticonvulsants. Eight of 54 confirmed NIRs showed positivity on immediate skin tests. Regulatory T cells, TGF-β and IL-10 levels were not different between groups with and without confirmed drug allergy. A strong family and personal history of drug allergy were found to be significantly related to the confirmed allergic drug reactions. Conclusion Parent or self-reported drug allergy should be evaluated with a standardized diagnostic work-up before strict prohibitions are made. In addition, family and personal histories of drug allergy were significant risk factors related to allergic drug reactions in children.
Literature
1.
go back to reference Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol. 2008;19(7):634–8.PubMed Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol. 2008;19(7):634–8.PubMed
2.
go back to reference Gomes E, Cardoso MF, Praca F, Gomes L, Marino E, Demoly P. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy. 2004;34(10):1597–601.PubMedCrossRef Gomes E, Cardoso MF, Praca F, Gomes L, Marino E, Demoly P. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy. 2004;34(10):1597–601.PubMedCrossRef
3.
go back to reference Orhan F, Karakas T, Cakir M, Akkol N, Bahat E, Sonmez FM, et al. Parental-reported drug allergy in 6- to 9-yr-old urban schoolchildren. Pediatr Allergy Immunol. 2008;19(1):82–5.PubMed Orhan F, Karakas T, Cakir M, Akkol N, Bahat E, Sonmez FM, et al. Parental-reported drug allergy in 6- to 9-yr-old urban schoolchildren. Pediatr Allergy Immunol. 2008;19(1):82–5.PubMed
4.
go back to reference Palma-Carlos AG, Medina G, Palma-Carlos ML. Prevalence of drug allergy in an out-patient population. Eur Ann Allergy Clin Immunol. 2006;38(5):142–5.PubMed Palma-Carlos AG, Medina G, Palma-Carlos ML. Prevalence of drug allergy in an out-patient population. Eur Ann Allergy Clin Immunol. 2006;38(5):142–5.PubMed
5.
go back to reference Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust. 2006;184(7):321–4.PubMed Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust. 2006;184(7):321–4.PubMed
6.
go back to reference Sanchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol. 2000;84(1):101–6.PubMedCrossRef Sanchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol. 2000;84(1):101–6.PubMedCrossRef
7.
go back to reference Pastorello EA, Zara C, Riario-Sforza GG, Pravettoni V, Incorvaia C. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy. 1998;53(9):880–4.PubMedCrossRef Pastorello EA, Zara C, Riario-Sforza GG, Pravettoni V, Incorvaia C. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy. 1998;53(9):880–4.PubMedCrossRef
8.
go back to reference Kurt E, Demir AU, Cadirci O, Yildirim H. Pinar Eser T. Immediate-type drug hypersensitivity and associated factors in a general population. Allergol Immunopathol. 2011;39(1):27–31.CrossRef Kurt E, Demir AU, Cadirci O, Yildirim H. Pinar Eser T. Immediate-type drug hypersensitivity and associated factors in a general population. Allergol Immunopathol. 2011;39(1):27–31.CrossRef
9.
go back to reference Langley J, Halperin S. Allergy to antibiotics in children: perception versus reality. Can J Infect Dis. 2002;13(3):160–3.PubMedCentralPubMed Langley J, Halperin S. Allergy to antibiotics in children: perception versus reality. Can J Infect Dis. 2002;13(3):160–3.PubMedCentralPubMed
10.
go back to reference Atanaskovic Markovic M, Velickovic TC, Gavrovic-Jankulovic M, Vuckovic O, Nestorovic B. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children. Pediatr Allergy Immunol. 2005;16(4):341–7.PubMedCrossRef Atanaskovic Markovic M, Velickovic TC, Gavrovic-Jankulovic M, Vuckovic O, Nestorovic B. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children. Pediatr Allergy Immunol. 2005;16(4):341–7.PubMedCrossRef
11.
go back to reference Gomes ER, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy. 2008;38(1):191–8. Gomes ER, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy. 2008;38(1):191–8.
12.
go back to reference Solensky R, Khan DA, Bernstein IL, Bloomberg GR, Castells MC, Mendelson LM, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259–73.CrossRef Solensky R, Khan DA, Bernstein IL, Bloomberg GR, Castells MC, Mendelson LM, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259–73.CrossRef
13.
go back to reference Romano A, Caubet JC. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract. 2014;2(1):3–12.PubMedCrossRef Romano A, Caubet JC. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract. 2014;2(1):3–12.PubMedCrossRef
14.
go back to reference Bousquet PJ, Gaeta F, Bousquet-Rouanet L, Lefrant JY, Demoly P, Romano A. Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des. 2008;14(27):2792–802.PubMedCrossRef Bousquet PJ, Gaeta F, Bousquet-Rouanet L, Lefrant JY, Demoly P, Romano A. Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des. 2008;14(27):2792–802.PubMedCrossRef
15.
go back to reference Palomares O, Martin Fontecha M, Lauener R, Traidl Hoffmann C, Cavkavtar O, Akdis M, et al. Regulatory T cells and immune regulation of allergic diseases: role of IL-10 and TGF-β. Genes Immun. 2014;15(8):511–20.PubMedCrossRef Palomares O, Martin Fontecha M, Lauener R, Traidl Hoffmann C, Cavkavtar O, Akdis M, et al. Regulatory T cells and immune regulation of allergic diseases: role of IL-10 and TGF-β. Genes Immun. 2014;15(8):511–20.PubMedCrossRef
16.
go back to reference Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity: questionnaire. EAACI Interest group on drug hypersensitivity. Allergy. 1999;54(9):999–1003.PubMedCrossRef Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity: questionnaire. EAACI Interest group on drug hypersensitivity. Allergy. 1999;54(9):999–1003.PubMedCrossRef
17.
go back to reference Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57(1):45–51.PubMed Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57(1):45–51.PubMed
18.
go back to reference Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58(9):854–63.PubMedCrossRef Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58(9):854–63.PubMedCrossRef
19.
go back to reference Blanca M, Romano A, Torres MJ, Fernandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy. 2009;64(2):183–93.PubMedCrossRef Blanca M, Romano A, Torres MJ, Fernandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy. 2009;64(2):183–93.PubMedCrossRef
20.
go back to reference Brockow K, Garvey LH, Aberer W, Atanaskovic Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs-an ENDA/EAACI drug allergy interest group position paper. Allergy. 2013;68(6):702–12.PubMedCrossRef Brockow K, Garvey LH, Aberer W, Atanaskovic Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs-an ENDA/EAACI drug allergy interest group position paper. Allergy. 2013;68(6):702–12.PubMedCrossRef
22.
go back to reference Seitz CS, Brocker EB, Trautmann A. Diagnosis of drug hypersensitivity in children and adolescents: discrepancy between physician-based assessment and results of testing. Pediatr Allergy Immunol. 2011;22(4):405–10.PubMedCrossRef Seitz CS, Brocker EB, Trautmann A. Diagnosis of drug hypersensitivity in children and adolescents: discrepancy between physician-based assessment and results of testing. Pediatr Allergy Immunol. 2011;22(4):405–10.PubMedCrossRef
23.
go back to reference Zambonino MA, Corzo JL, Munoz C, Requena G, Ariza A, Mayorga C, et al. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol. 2014;25(1):80–7.PubMedCrossRef Zambonino MA, Corzo JL, Munoz C, Requena G, Ariza A, Mayorga C, et al. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol. 2014;25(1):80–7.PubMedCrossRef
24.
go back to reference Ponvert C, Le Clainche L, de Blic J, Le Bourgeois M, Scheinmann P, Paupe J. Allergy to beta-lactam antibiotics in children. Pediatrics. 1999;104(4):e45.PubMedCrossRef Ponvert C, Le Clainche L, de Blic J, Le Bourgeois M, Scheinmann P, Paupe J. Allergy to beta-lactam antibiotics in children. Pediatrics. 1999;104(4):e45.PubMedCrossRef
25.
go back to reference Ponvert C, Perrin Y, Bados-Albiero A, Le Bourgeois M, Karila C, Delacourt C, et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011;22(4):411–8.PubMedCrossRef Ponvert C, Perrin Y, Bados-Albiero A, Le Bourgeois M, Karila C, Delacourt C, et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011;22(4):411–8.PubMedCrossRef
26.
go back to reference Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr. 1998;132(1):137–43.PubMedCrossRef Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr. 1998;132(1):137–43.PubMedCrossRef
27.
go back to reference Benahmed S, Scaramuzza C, Messaad D, Sahla H, Demoly P. The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial. Allergy. 2004;59(10):1130–3.PubMedCrossRef Benahmed S, Scaramuzza C, Messaad D, Sahla H, Demoly P. The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial. Allergy. 2004;59(10):1130–3.PubMedCrossRef
28.
go back to reference Seitz CS, Brocker EB, Trautmann A. Suspicion of macrolide allergy after treatment of infectious diseases including Helicobacter pylori: results of allergological testing. Allergol Immunopathol. 2011;39(4):193–9.CrossRef Seitz CS, Brocker EB, Trautmann A. Suspicion of macrolide allergy after treatment of infectious diseases including Helicobacter pylori: results of allergological testing. Allergol Immunopathol. 2011;39(4):193–9.CrossRef
29.
go back to reference Zambonino MA, Torres MJ, Munoz C, Requena G, Mayorga C, Posadas T, et al. Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol. 2013;24(2):151–9.PubMedCrossRef Zambonino MA, Torres MJ, Munoz C, Requena G, Mayorga C, Posadas T, et al. Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol. 2013;24(2):151–9.PubMedCrossRef
30.
go back to reference Yilmaz O, Karagol HE, Bakirtas A, Topal E, Celik GE, Demirsoy MS, et al. Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children. Allergy. 2013;68(12):1555–61.PubMedCrossRef Yilmaz O, Karagol HE, Bakirtas A, Topal E, Celik GE, Demirsoy MS, et al. Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children. Allergy. 2013;68(12):1555–61.PubMedCrossRef
31.
go back to reference Blanca M, Torres MJ, Garcia JJ, Romano A, Mayorga C, de Ramon E, et al. Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol. 1999;103:918–24.PubMedCrossRef Blanca M, Torres MJ, Garcia JJ, Romano A, Mayorga C, de Ramon E, et al. Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol. 1999;103:918–24.PubMedCrossRef
32.
go back to reference Hjortlund J, Mortz CG, Skov PS, Bindslev-Jensen C. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy. 2013;68(8):1057–64.PubMedCrossRef Hjortlund J, Mortz CG, Skov PS, Bindslev-Jensen C. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy. 2013;68(8):1057–64.PubMedCrossRef
33.
go back to reference Bircher AJ, Scherer Hofmeier K. Drug hypersensitivity reactions: inconsistency in the use of the classification of immediate and nonimmediate reactions. J Allergy Clin Immunol. 2012;129(1):263–4.PubMedCrossRef Bircher AJ, Scherer Hofmeier K. Drug hypersensitivity reactions: inconsistency in the use of the classification of immediate and nonimmediate reactions. J Allergy Clin Immunol. 2012;129(1):263–4.PubMedCrossRef
34.
go back to reference Stember RH. Prevalence of skin test reactivity in patients with convincing, vague and unacceptable histories of penicillin allergy. Allergy Asthma Proc. 2005;26(1):59–64.PubMed Stember RH. Prevalence of skin test reactivity in patients with convincing, vague and unacceptable histories of penicillin allergy. Allergy Asthma Proc. 2005;26(1):59–64.PubMed
35.
go back to reference Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol. 1998;139(1):49–58.PubMedCrossRef Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol. 1998;139(1):49–58.PubMedCrossRef
36.
go back to reference Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective Regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol. 2009;182(12):8071–9.PubMedCrossRef Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective Regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol. 2009;182(12):8071–9.PubMedCrossRef
37.
go back to reference Qiao HL, Wen Q, Gao N, Tian X, Jia LJ. Association of IL-10 level and IL-10 promoter SNPs with specific antibodies in penicillin-allergic patients. Eur J Clin Pharmacol. 2007;63(3):263–9.PubMedCrossRef Qiao HL, Wen Q, Gao N, Tian X, Jia LJ. Association of IL-10 level and IL-10 promoter SNPs with specific antibodies in penicillin-allergic patients. Eur J Clin Pharmacol. 2007;63(3):263–9.PubMedCrossRef
38.
go back to reference Lieber NS, Ribeiro E. Adverse drug reactions leading children to the emergency department. Rev Bras Epidemiol. 2012;15(2):265–74.PubMedCrossRef Lieber NS, Ribeiro E. Adverse drug reactions leading children to the emergency department. Rev Bras Epidemiol. 2012;15(2):265–74.PubMedCrossRef
39.
go back to reference Rashed AN, Wong IC, Cranswick N, Tomlin S, Rascher W, Neubert A. Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. Eur J Clin Pharmacol. 2012;68(5):801–10.PubMedCrossRef Rashed AN, Wong IC, Cranswick N, Tomlin S, Rascher W, Neubert A. Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. Eur J Clin Pharmacol. 2012;68(5):801–10.PubMedCrossRef
40.
go back to reference Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol. 2007;33(1):124–33.PubMedCrossRef Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol. 2007;33(1):124–33.PubMedCrossRef
41.
go back to reference Hassani A, Ponvert C, Karila C, Le Bourgeois M, De Blic J, Scheinmann P. Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases. Eur J Dermatol. 2008;18(5):561–5.PubMed Hassani A, Ponvert C, Karila C, Le Bourgeois M, De Blic J, Scheinmann P. Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases. Eur J Dermatol. 2008;18(5):561–5.PubMed
Metadata
Title
Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests
Authors
Tugba Arikoglu
Gulen Aslan
Sehra Birgul Batmaz
Gulcin Eskandari
Ilter Helvaci
Semanur Kuyucu
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 4/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0100-9

Other articles of this Issue 4/2015

International Journal of Clinical Pharmacy 4/2015 Go to the issue